Finding a cure for glioblastoma -the most common type of brain cancer - has proved difficult because of the biology of the brain. A new trial is set to use the DNA of patients and tailor treatments to ...
A new study describes the development of a biologic, a drug derived from natural biological systems, that targets a mutant cancer protein called HER2 (human epidermal growth factor receptor 2) without ...